Nitric oxide synthase 3 deficiency limits adverse ventricular remodeling after pressure overload in insulin resistance

Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2093-101. doi: 10.1152/ajpheart.00744.2010. Epub 2011 Aug 19.

Abstract

Insulin resistance (IR) and systemic hypertension are independently associated with heart failure. We reported previously that nitric oxide synthase 3 (NOS3) has a beneficial effect on left ventricular (LV) remodeling and function after pressure-overload in mice. The aim of our study was to investigate the interaction of IR and NOS3 in pressure-overload-induced LV remodeling and dysfunction. Wild-type (WT) and NOS3-deficient (NOS3(-/-)) mice were fed either a standard diet (SD) or a high-fat diet (HFD) to induce IR. After 9 days of diet, mice underwent transverse aortic constriction (TAC). LV structure and function were assessed serially using echocardiography. Cardiomyocytes were isolated, and levels of oxidative stress were evaluated using 2',7'-dichlorodihydrofluorescein diacetate. Cardiac mitochondria were isolated, and mitochondrial respiration and ATP production were measured. TAC induced LV remodeling and dysfunction in all mice. The TAC-induced decrease in LV function was greater in SD-fed NOS3(-/-) mice than in SD-fed WT mice. In contrast, HFD-fed NOS3(-/-) developed less LV remodeling and dysfunction and had better survival than did HFD-fed WT mice. Seven days after TAC, oxidative stress levels were lower in cardiomyocytes from HFD-fed NOS3(-/-) than in those from HFD-fed WT. N(ω)-nitro-L-arginine methyl ester and mitochondrial inhibitors (rotenone and 2-thenoyltrifluoroacetone) decreased oxidative stress levels in cardiomyocytes from HFD-fed WT mice. Mitochondrial respiration was altered in NOS3(-/-) mice but did not worsen after HFD and TAC. In contrast with its protective role in SD, NOS3 increases LV adverse remodeling after pressure overload in HFD-fed, insulin resistant mice. Interactions between NOS3 and mitochondria may be responsible for increased oxidative stress levels in HFD-fed WT mice hearts.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Dietary Fats / administration & dosage
  • Disease Models, Animal
  • Energy Metabolism
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation, Enzymologic
  • Heart Failure / enzymology
  • Heart Failure / etiology*
  • Heart Failure / genetics
  • Heart Failure / physiopathology
  • Hydrogen Peroxide / metabolism
  • Hypertension / complications*
  • Hypertension / diagnostic imaging
  • Hypertension / enzymology
  • Hypertension / genetics
  • Hypertension / physiopathology
  • Insulin Resistance* / genetics
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mitochondria, Heart / enzymology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / enzymology*
  • Myocytes, Cardiac / pathology
  • Nitric Oxide Synthase Type III / antagonists & inhibitors
  • Nitric Oxide Synthase Type III / deficiency*
  • Nitric Oxide Synthase Type III / genetics
  • Oxidative Stress
  • Phosphorylation
  • Serine
  • Time Factors
  • Ultrasonography
  • Uncoupling Agents / pharmacology
  • Ventricular Dysfunction, Left / diagnostic imaging
  • Ventricular Dysfunction, Left / enzymology
  • Ventricular Dysfunction, Left / etiology*
  • Ventricular Dysfunction, Left / genetics
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Function, Left* / drug effects
  • Ventricular Remodeling* / drug effects

Substances

  • Dietary Fats
  • Enzyme Inhibitors
  • Uncoupling Agents
  • Serine
  • Adenosine Triphosphate
  • Hydrogen Peroxide
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse